Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Health Catalyst ( (HCAT) ) has shared an announcement.
On February 12, 2026, Health Catalyst, Inc. Chief Executive Officer and principal executive officer Daniel Burton accelerated the effective date of his previously announced retirement to that same day, marking an earlier‑than‑expected leadership transition at the healthcare data and analytics company. To facilitate continuity, the company entered into a transition agreement with Burton on March 31, 2026, under which he will serve as a strategic advisor through December 31, 2026 in return for a $10,000 average monthly base salary starting March 1, 2026, while forfeiting all unvested restricted stock units and performance-based restricted stock units eligible to vest after March 2, 2026 and providing a general release of claims against the company.
The most recent analyst rating on (HCAT) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Health Catalyst stock, see the HCAT Stock Forecast page.
Spark’s Take on HCAT Stock
According to Spark, TipRanks’ AI Analyst, HCAT is a Neutral.
The score is weighed down primarily by weak financial performance (widening losses, softening revenue, and negative free cash flow) and bearish technicals (price far below key moving averages with negative MACD). Earnings-call commentary shows improving adjusted profitability and cost discipline, but near-term revenue pressure, withheld full-year guidance, and sizable migration-driven ARR risk limit confidence; valuation support is also constrained by negative earnings.
To see Spark’s full report on HCAT stock, click here.
More about Health Catalyst
Health Catalyst, Inc. operates in the healthcare technology and analytics industry, providing data and analytics platforms and related services to healthcare organizations. The company focuses on improving clinical, financial, and operational outcomes for hospitals, health systems, and other healthcare stakeholders through its software and services portfolio.
Average Trading Volume: 846,444
Technical Sentiment Signal: Sell
Current Market Cap: $86.1M
Learn more about HCAT stock on TipRanks’ Stock Analysis page.